News
News
Healthtech
Pharma
Hospitals & Providers
Diagnostics
Medical Devices
Policy & Public Health
Finance
Precision Medicine
Global
Podcast
Insights
VOH Exclusives
VOH Exclusives
Brands in Focus
Idea Leader
Listicles
Editorials
VOH TV
VOH TV
Expert Speaks
The Big Idea
Daily Broadcast
Events
Events
Health Awareness
Conferences & Summits
Brand Solutions
Sickle cell Disease
Pharma
FDA Grants Orphan Drug Designation to Rilzabrutinib for Sickle Cell Disease-Related Pain Crises
Rahul
05 Jun 2025
2 min read
Voice Of HealthCare
vohnetwork.com
INSTALL APP
